Leveraging immunoprecipitation mass spectrometry and neuropathology to identify the clinical value of different blood tau species in Alzheimer's disease.
- DOI
- 10.1007/s00415-026-14232-y
- Published
- 2026 Oct 31
- Container
- Journal of neurology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00415-026-14232-y,
title = {Leveraging immunoprecipitation mass spectrometry and neuropathology to identify the clinical value of different blood tau species in Alzheimer's disease.},
author = {Labonte J and Miner AE and Groh JR and Montoliu-Gaya L and Tripodis Y and Aparicio HJ and Turk KW and Budson AE and Farrer L and Goldstein LE and Qiu WQ and Mez J and McKee AC and Zetterberg H and Stein TD and Gobom J and Ashton NJ and Alosco ML},
year = {2026},
journal = {Journal of neurology},
doi = {10.1007/s00415-026-14232-y},
url = {https://doi.org/10.1007/s00415-026-14232-y}
}RIS
TY - JOUR TI - Leveraging immunoprecipitation mass spectrometry and neuropathology to identify the clinical value of different blood tau species in Alzheimer's disease. AU - Labonte J AU - Miner AE AU - Groh JR AU - Montoliu-Gaya L AU - Tripodis Y AU - Aparicio HJ AU - Turk KW AU - Budson AE AU - Farrer L AU - Goldstein LE AU - Qiu WQ AU - Mez J AU - McKee AC AU - Zetterberg H AU - Stein TD AU - Gobom J AU - Ashton NJ AU - Alosco ML PY - 2026 JO - Journal of neurology DO - 10.1007/s00415-026-14232-y UR - https://doi.org/10.1007/s00415-026-14232-y ER -
APA
J, L., AE, M., JR, G., L, M., Y, T., HJ, A., KW, T., AE, B., L, F., LE, G., WQ, Q., J, M., AC, M., H, Z., TD, S., J, G., NJ, A., & ML, A. (2026). Leveraging immunoprecipitation mass spectrometry and neuropathology to identify the clinical value of different blood tau species in Alzheimer's disease.. Journal of neurology. https://doi.org/10.1007/s00415-026-14232-y
Source records
- pubmed · retrieved 2026-11-10T11:31:53.141Z